Brief Report: Validation of a Urine Tenofovir Immunoassay for Adherence Monitoring to PrEP and ART and Establishing the Cutoff for a Point-of-Care Test
Monica Gandhi(University of California, San Francisco), Paul K. Drain(University of Washington), Warren C. Rodrigues, Hideaki Okochi, Oraphan Siriprakaisil(SanPaTong Hospital), Peter Bacchetti(University of California, San Francisco), Jared M. Baeten(University of Washington), Virat Klinbuayaem(SanPaTong Hospital), Michael S. Vincent(Pfizer (United States)), Tim R. Cressey, Guohong Wang(Fudan University), Matthew A. Spinelli(University of California, San Francisco)
Cited by 93
Related Papers
Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis
|The Lancet|2022|16k
Antiretroviral Prophylaxis for HIV Prevention in Heterosexual Men and Women
|New England Journal of Medicine|2012|3.3k
Liver Transplantation for Hepatocellular Carcinoma: Expansion of the Tumor Size Limits Does Not Adversely Impact Survival
|Hepatology|2001|2.3k
Heterosexual HIV-1 transmission after initiation of antiretroviral therapy: a prospective cohort analysis
|The Lancet|2010|958
Use of a Vaginal Ring Containing Dapivirine for HIV-1 Prevention in Women
|New England Journal of Medicine|2016|768